Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-10-264807
Filing Date
2010-11-19
Accepted
2010-11-19 10:17:56
Documents
1
Effectiveness Date
2010-11-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 17807
  Complete submission text file 0001193125-10-264807.txt   19170
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 101204389
SIC: 2835 In Vitro & In Vivo Diagnostic Substances